Author + information
- Received December 20, 1996
- Revision received May 20, 1997
- Accepted May 30, 1997
- Published online July 1, 1997.
- Anji T Yetman, MD, FRCPCA,
- David Nykanen, MD, FRCPCA,
- Brian W McCrindle, MD, FRCPC, FACCA,
- Jan Sunnegardh, MDA,
- Ian Adatia, MBChB, FRCPC, MRCPA,
- Robert M Freedom, MD, FRCPC, FACCA and
- Lee Benson, MD, FRCPC, FACCA,* ()
- ↵*Dr. Lee Benson, The Hospital for Sick Children, 555 University Avenue, Toronto, Ontario, Canada M5G 1X8.
Objectives. This study was undertaken to investigate the long-term outcome of balloon angioplasty for recurrent coarctation of the aorta in a large series of patients.
Background. Balloon angioplasty has become the standard treatment for residual or recurrent aortic coarctation. Despite the widespread use of this treatment modality, there are few data outlining the long-term outcome of a large patient cohort.
Methods. Clinical, echocardiographic, hemodynamic and angiographic data on 90 consecutive patients who underwent balloon angioplasty between January 1984 and January 1996 were reviewed.
Results. Mean systolic pressure gradients were reduced from 31 ± 21 to 8 ± 9 mm Hg after dilation (p = 0.0001). The mean diameter of the stenotic site, measured in the frontal and lateral views, increased by 38% and 35%, respectively (p = 0.001). Neurologic events occurred in two patients, with one death. An aortic tear occurred in one patient, requiring surgical intervention. Optimal results were defined as a postprocedure gradient <20 mm Hg and were obtained acutely in 88% of patients. At long-term follow-up (12 years), 53 (72%) of 74 patients with an early optimal result remained free from reintervention. Transverse arch hypoplasia, defined as an arch dimension <2 SD below the mean for age, was the primary predictor of the need for reintervention.
Conclusions. Although the majority of patients undergoing percutaneous balloon angioplasty for recoarctation of the aorta will achieve long-term benefit, the need for further surgical intervention in those with transverse arch hypoplasia remains high.
- Received December 20, 1996.
- Revision received May 20, 1997.
- Accepted May 30, 1997.